⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10425151 | 0.85 | ELANE (0.39) | — | |
| SCHEMBL16823391 | 0.83 | CA1 (0.44) | — | |
| SCHEMBL28413724 | 0.81 | CTRC (0.43) | — | |
| SCHEMBL7983997 | 0.80 | LIPG (0.44) | — | |
| SCHEMBL1532454 | 0.79 | — | — | |
| SCHEMBL30458138 | 0.79 | GABRA1 (0.45) | — | |
| Bromide SCHEMBL29257750 | 0.77 | LIPG (0.46) | — | |
| SCHEMBL4649113 | 0.74 | AKR1B1 (0.50) | — | |
| SCHEMBL9618185 | 0.74 | IDO1 (0.44) | — | |
| SCHEMBL11131884 | 0.74 | GABRA1 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0798304-A1 | REMEDIES FOR THROMBOCYTOPENIA | SUNTORY LIMITED (JP) | 1997-10-01 | — | — | EP | claimed |
| CN-119330924-A | Preparation method of alkyl pyran 3, 5-difluorobenzene | 石家庄市凯信电子材料有限公司 | 2025-01-21 | — | — | CN | disclosed |
| US-11555115-B2 | Bioderived monomers as replacements in petroleum based polymers and copolymers | ALLIANCE FOR SUSTAINABLE ENERGY, LLC (US) | 2023-01-17 | — | — | US | disclosed |
| CN-103086945-A | Synthetic process of important pharmaceutical chemical intermediate tryptamine | ZHANGJIAGANG WEISHENG BIOLOG PHARMACEUTICAL CO LTD | 2013-05-08 | — | — | CN | disclosed |
| CN-102753145-A | Liquid composition comprising a non-menthol cooling agent and a thickening agent for treating respiratory symptoms | PROCTER & GAMBLE | 2012-10-24 | — | — | CN | disclosed |
| CN-102485723-A | Semi-synthesis of vinpocetine through one kettle way and preparation of water-soluble vinpocetine salt | JIANGSU SWELLXIN BIO PHARM PTY LTD | 2012-06-06 | — | — | CN | disclosed |
| US-20110014504-A1 | LITHIUM SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2011-01-20 | — | — | US | disclosed |
| CN-101868252-A | Formulations, methods and kits useful for treating cough | PROCTER & GAMBLE | 2010-10-20 | — | — | CN | disclosed |
| US-20080311478-A1 | Lithium Secondary Battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2008-12-18 | — | — | US | disclosed |
| EP-1892789-A1 | LITHIUM SECONDARY BATTERY | Mitsubishi Chemical Corporation (JP) | 2008-02-27 | — | — | EP | disclosed |
| US-6184393-B1 | MYXOPYRONINS AND CORALLOPYRONINS AS FURAN AND PYRAN- AND SMALL LACTONE-ANTIBIOTICS; INHIBITORS OF RNA POLYMERASE (RNAP) HAVING SELECTIVITY FOR HUMAN RNAP, CELL PENETRATION AND POTENCY AGAINST RIFAMPICIN-RESISTANT STAPH. AUREUS | TRUSTEES OF BOSTON UNIVERSITY | 2001-02-06 | — | — | US | disclosed |
| EP-1043990-A1 | PYRONIN ANTIBACTERIALS, PROCESS AND NOVEL INTERMEDIATES THERETO | Scriptgen Pharmaceuticals, Inc. (US) | 2000-10-18 | — | — | EP | disclosed |
| US-6127551-A | 4-HYDROXY-6-ETHYOXYCARBONYLALKENYL-2H-PYRAN-2-ONE IS ACYLATED WITH PROPIONYL CHLORIDE TO FORM A KETONE ADDUCT, FOLLOWED BY BASE-CATALYZED ALDOL TO FROM A PYRONE ALDOL; MESYLATION, FORM A PYRONE KETONE; AND CURTIUS SEQUENCE TO FORM MYXOPYRONIN | SCRIPTGEN PHARMACEUTICALS, INC. (US) | 2000-10-03 | — | — | US | disclosed |
| US-6090953-A | PREPARING A MYXOPYRONIN | SCRIPTGEN PHARMACEUTICALS, INC. (US) | 2000-07-18 | — | — | US | disclosed |
| WO-2000015626-A1 | PROCESS FOR THE PREPARATION OF INTERMEDIATES FOR PYRONIN ANTIBACTERIALS | ANADYS PHARMACEUTICALS, INC. (US) | 2000-03-23 | — | — | WO | disclosed |
| US-6022983-A | PREPARING A MYXOPYRONIN | SCRIPTGEN PHARMACEUTICALS, INC. (US) | 2000-02-08 | — | — | US | disclosed |
| US-5986111-A | CONDENSATION OF ALDEHYDE WITH PYRONE TO FORM ADDUCT, OXIDATION AND SAPONIFICATION | SCRIPTGEN PHARMACEUTICALS, INC. (US) | 1999-11-16 | — | — | US | disclosed |
| WO-1999034793-A1 | PYRONIN ANTIBACTERIALS, PROCESS AND NOVEL INTERMEDIATES THERETO | SCRIPTGEN PHARMACEUTICALS, INC. (US) | 1999-07-15 | — | — | WO | disclosed |
| EP-0892774-A2 | PYRONIN ANTIBACTERIALS, PROCESS AND NOVEL INTERMEDIATES THERETO | SCRIPTGEN PHARMACEUTICALS, INC. (US) | 1999-01-27 | — | — | EP | disclosed |
| WO-1997034569-A2 | PYRONIN ANTIBACTERIALS, PROCESS AND INTERMEDIATES | SCRIPTGEN PHARMACEUTICALS, INC. (US) | 1997-09-25 | — | — | WO | disclosed |